Yes, restless legs syndrome (RLS) is a neurological disorder. The National Institute of Neurological Disorders and Stroke classifies it as a neurological condition that causes an irresistible urge to move the legs, and it falls under the institute’s research and clinical umbrella alongside conditions like Parkinson’s disease and epilepsy. The distinction matters because it means RLS originates in the brain, not in the muscles or blood vessels of the legs, and that shapes how it’s diagnosed and treated.
What Happens in the Brain
RLS appears to involve dysfunction in the basal ganglia, a deep brain region responsible for producing smooth, purposeful movement. The basal ganglia relies heavily on dopamine, a chemical messenger that coordinates muscle activity. When dopamine signaling is disrupted, the result can be involuntary or uncontrollable urges to move.
Iron plays a central role in this process. The brain needs iron to produce dopamine at a critical step in its manufacturing chain. When brain iron levels are low, dopamine production falters, and the receptors that receive dopamine signals also change in number and sensitivity. Animal studies show that iron-deprived brains have fewer dopamine receptors and altered dopamine levels in the movement-control circuits. This iron-dopamine connection helps explain why many people with RLS have low iron stores even when their blood counts appear normal, and why iron supplementation sometimes improves symptoms.
The Genetic Component
Large-scale genetic studies have identified at least four chromosomal regions linked to RLS risk, involving genes known as MEIS1, BTBD9, MAP2K5/SKOR1, and PTPRD. Of these, MEIS1 and BTBD9 carry the strongest associations. People who carry certain variants of BTBD9, for example, have roughly 1.5 times the odds of developing RLS compared to those without the variant. These genes are involved in early nervous system development and iron regulation, reinforcing the idea that RLS is rooted in how the brain is built and how it manages its chemical resources. If a parent or sibling has RLS, your own risk is meaningfully higher.
How RLS Is Diagnosed
There is no blood test or brain scan for RLS. Diagnosis rests on four clinical criteria established by the International Restless Legs Syndrome Study Group:
- An urge to move the legs, usually accompanied by uncomfortable or unpleasant sensations.
- Motor restlessness, meaning you move to relieve the discomfort, whether by walking, stretching, or rubbing your legs.
- Symptoms worsen at rest and improve at least temporarily with activity.
- Symptoms are worse in the evening or at night.
All four must be present. The evening and nighttime pattern is a key distinguishing feature. Leg discomfort from poor circulation or nerve damage tends to occur with standing or exertion regardless of time of day, while RLS characteristically flares when you’re sitting still or lying in bed.
How RLS Affects Sleep
Because symptoms peak at night, RLS is one of the most disruptive neurological conditions for sleep. Untreated patients show significant reductions in total sleep time and sleep efficiency, longer time to fall asleep, and more time spent awake after initially dozing off. The sleep they do get is lighter: time in deeper restorative stages and REM sleep drops, while the lightest stage of sleep increases along with frequent arousals throughout the night.
The downstream effects extend beyond tiredness. Chronic sleep fragmentation from RLS is associated with daytime fatigue, difficulty with attention and concentration, and cognitive complaints affecting overall mental sharpness. A 2024 survey from the American Academy of Sleep Medicine found that 13% of Americans report having been diagnosed with RLS, making it far more common than many people realize.
The Connection to Parkinson’s Disease
Both RLS and Parkinson’s disease involve dopamine dysfunction in the basal ganglia, which has led researchers to investigate whether the two are linked. A meta-analysis covering nearly 7,000 Parkinson’s patients found that about 20% also had RLS, a rate notably higher than in the general population. This overlap suggests the two conditions share some underlying biology, though RLS does not inevitably progress to Parkinson’s. The relationship is more of a shared vulnerability in brain chemistry than a direct pathway from one disease to the other.
How Treatment Has Shifted
Because RLS involves dopamine, medications that boost dopamine activity were the go-to treatment for years. They work quickly and effectively in the short term. The problem is a phenomenon called augmentation: over time, dopamine-boosting drugs can actually make RLS worse. Symptoms may start occurring earlier in the day, spread to the arms, or become more intense than they were before treatment.
The 2025 clinical practice guideline from the American Academy of Sleep Medicine reflects this hard-learned lesson. Dopamine-boosting medications are now conditionally recommended against as standard treatments for RLS. Instead, a class of nerve-calming medications (alpha-2-delta ligands, which include gabapentin and pregabalin) has moved into the strongly recommended category based on multiple high-quality trials showing effectiveness without the augmentation risk. Dopamine-based drugs may still be appropriate for certain individuals who prefer short-term relief and accept the long-term trade-offs, but they are no longer the default.
Iron supplementation remains an important piece of the puzzle for people whose ferritin levels (a measure of iron stores) are on the low side, since correcting brain iron deficiency can address one of the root causes rather than just masking symptoms.
Why the Neurological Label Matters
Understanding RLS as a neurological disorder changes how you think about it and, often, how seriously it gets taken. For decades, RLS was dismissed as simple restlessness or anxiety. Knowing that it stems from measurable brain chemistry and identifiable genetic variants puts it in the same category as other recognized neurological conditions. It also explains why willpower alone cannot override the urge to move: the signals are coming from deep brain circuits that operate below conscious control. If you or someone you know has symptoms that match the four diagnostic criteria, a neurologist or sleep specialist is the most direct path to an accurate diagnosis and current treatment options.